These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1603 related items for PubMed ID: 16386671

  • 1. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Daubert JP, Zareba W, Hall WJ, Schuger C, Corsello A, Leon AR, Andrews ML, McNitt S, Huang DT, Moss AJ, MADIT II Study Investigators.
    J Am Coll Cardiol; 2006 Jan 03; 47(1):98-107. PubMed ID: 16386671
    [Abstract] [Full Text] [Related]

  • 2. Ventricular arrhythmia inducibility predicts subsequent ICD activation in nonischemic cardiomyopathy patients: a DEFINITE substudy.
    Daubert JP, Winters SL, Subacius H, Berger RD, Ellenbogen KA, Taylor SG, Schaechter A, Howard A, Kadish A, Defibrillators In Nonischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators.
    Pacing Clin Electrophysiol; 2009 Jun 03; 32(6):755-61. PubMed ID: 19545338
    [Abstract] [Full Text] [Related]

  • 3. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).
    Singh JP, Hall WJ, McNitt S, Wang H, Daubert JP, Zareba W, Ruskin JN, Moss AJ, MADIT-II Investigators.
    J Am Coll Cardiol; 2005 Nov 01; 46(9):1712-20. PubMed ID: 16256874
    [Abstract] [Full Text] [Related]

  • 4. Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.
    Vyas AK, Guo H, Moss AJ, Olshansky B, McNitt SA, Hall WJ, Zareba W, Steinberg JS, Fischer A, Ruskin J, Andrews ML, MADIT-II Research Group.
    J Am Coll Cardiol; 2006 Feb 21; 47(4):769-73. PubMed ID: 16487843
    [Abstract] [Full Text] [Related]

  • 5. QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Haigney MC, Zareba W, Gentlesk PJ, Goldstein RE, Illovsky M, McNitt S, Andrews ML, Moss AJ, Multicenter Automatic Defibrillator Implantation Trial II investigators.
    J Am Coll Cardiol; 2004 Oct 06; 44(7):1481-7. PubMed ID: 15464332
    [Abstract] [Full Text] [Related]

  • 6. Induction of ventricular fibrillation rather than ventricular tachycardia predicts tachyarrhythmia recurrences in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillator for secondary prophylaxis.
    Rolf S, Haverkamp W, Borggrefe M, Breithardt G, Bocker D.
    Europace; 2009 Mar 06; 11(3):289-96. PubMed ID: 19095687
    [Abstract] [Full Text] [Related]

  • 7. Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study.
    Klein G, Lissel C, Fuchs AC, Gardiwal A, Oswald H, Desousa M, Pichlmaier AM, Lichtinghagen R, Geerlings H, Lippolt P, Niehaus M, Drexler H, Korte T.
    Europace; 2006 Aug 06; 8(8):618-24. PubMed ID: 16864615
    [Abstract] [Full Text] [Related]

  • 8. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD, Doshi RN, Belott P, Birgersdotter-Green U, Behboodikhah M, Ott P, Glatter KA, Tobias S, Frumin H, Lee BK, Merillat J, Wiener I, Wang S, Grogin H, Chun S, Patrawalla R, Crandall B, Osborn JS, Weiss JP, Lappe DL, Neuman S.
    Circulation; 2007 May 08; 115(18):2382-9. PubMed ID: 17470697
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Characteristics and relevance of clustering ventricular arrhythmias in defibrillator recipients.
    Stuber T, Eigenmann C, Delacrétaz E.
    Pacing Clin Electrophysiol; 2005 Jul 08; 28(7):702-7. PubMed ID: 16008807
    [Abstract] [Full Text] [Related]

  • 11. Sustained polymorphic arrhythmias induced by programmed ventricular stimulation have prognostic value in patients receiving defibrillators.
    Greenberg SL, Mauricio Sánchez J, Cooper JA, Cain ME, Chen J, Gleva MJ, Lindsay BD, Smith TW, Faddis MN.
    Pacing Clin Electrophysiol; 2007 Sep 08; 30(9):1067-75. PubMed ID: 17725748
    [Abstract] [Full Text] [Related]

  • 12. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW, Birgersdotter-Green UM, Wathen MS, Van Gelder IC, Heubner BM, Brown ML, Holloman KK, PREPARE Study Investigators.
    J Am Coll Cardiol; 2008 Aug 12; 52(7):541-50. PubMed ID: 18687248
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Predictive value of programmed ventricular stimulation in patients with ischaemic cardiomyopathy: implications for the selection of candidates for an implantable defibrillator.
    De Ferrari GM, Rordorf R, Frattini F, Petracci B, De Filippo P, Landolina M.
    Europace; 2007 Dec 12; 9(12):1151-7. PubMed ID: 17947251
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia.
    Corrado D, Calkins H, Link MS, Leoni L, Favale S, Bevilacqua M, Basso C, Ward D, Boriani G, Ricci R, Piccini JP, Dalal D, Santini M, Buja G, Iliceto S, Estes NA, Wichter T, McKenna WJ, Thiene G, Marcus FI.
    Circulation; 2010 Sep 21; 122(12):1144-52. PubMed ID: 20823389
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of first ventricular tachycardia cycle length on rate of ventricular arrhythmia recurrence in patients with implantable cardioverter-defibrillator.
    Arya A, Haghjoo M, Nikoo MH, Dehghani MR, Fazelifar AF, Sadr-Ameli MA.
    J Electrocardiol; 2006 Oct 21; 39(4):404-8. PubMed ID: 16895771
    [Abstract] [Full Text] [Related]

  • 19. Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac resynchronization therapy patients.
    Wilkoff BL, Hess M, Young J, Abraham WT.
    J Cardiovasc Electrophysiol; 2004 Sep 21; 15(9):1002-9. PubMed ID: 15363071
    [Abstract] [Full Text] [Related]

  • 20. Obesity as a risk factor for sustained ventricular tachyarrhythmias in MADIT II patients.
    Pietrasik G, Goldenberg I, McNitt S, Moss AJ, Zareba W.
    J Cardiovasc Electrophysiol; 2007 Feb 21; 18(2):181-4. PubMed ID: 17338766
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 81.